| Miguel Angel Jordan, MD | |
|
1900 Chapel Dr, Findlay, OH 45840-1296 | |
| (419) 425-3211 | |
| (419) 425-4440 |
| Full Name | Miguel Angel Jordan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 1900 Chapel Dr, Findlay, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750417788 | NPI | - | NPPES |
| 0792870 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blanchard Valley Hospital | Findlay, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blanchard Valley Medical Practice Llc | 9234168147 | 68 |
News Archive
A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth.
An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.
Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 9 days ago
| Entity Name | Henry County Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407880909 PECOS PAC ID: 0345141644 Enrollment ID: O20040120000128 |
News Archive
A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth.
An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.
Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 9 days ago
| Entity Name | Jtdm Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184652539 PECOS PAC ID: 2163415837 Enrollment ID: O20040407000863 |
News Archive
A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth.
An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.
Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 9 days ago
| Entity Name | Blanchard Valley Medical Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962501627 PECOS PAC ID: 9234168147 Enrollment ID: O20050811000177 |
News Archive
A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth.
An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.
Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miguel Angel Jordan, MD 1900 Chapel Dr, Findlay, OH 45840-1296 Ph: (419) 425-3211 | Miguel Angel Jordan, MD 1900 Chapel Dr, Findlay, OH 45840-1296 Ph: (419) 425-3211 |
News Archive
A team of scientists from Mayo Clinic, the University of Illinois at Urbana-Champaign, and the J. Craig Venter Institute are leveraging a long-standing research relationship to apply results from the Human Microbiome Project to help identify microbial risk predictors for preterm birth.
An expert panel was formed in the United States to advise the government on how to deal with the problem of antimicrobial resistance (AMR), a growing menace. This panel has now come up with a set of recommendations that could help reduce AMR in humans and animals. Recommendations include development of new vaccines against infections, development of better diagnostic tools to detect the infections early and also new therapies to handle the infections.
Amid shifting scientific data on nutrition and obesity, experts from government, industry, and academia converged on Harvard Medical School last week to discuss obesity's causes and how to craft a coherent public nutritional message.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
› Verified 9 days ago
Dr. Joseph Aloysius Weingates Iii, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1818 Chapel Dr, Suite C, Findlay, OH 45840 Phone: 419-424-1055 Fax: 419-424-9448 | |
George Abate, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1818 Chapel Dr, Suite C, Findlay, OH 45840 Phone: 419-427-0809 | |
Carmen Doty-armstrong, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main Cross St, Findlay, OH 45840 Phone: 419-420-0904 Fax: 419-420-1893 | |
Dr. Mahendra C. Parekh, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 West Wallace Street, Suite B-4, Findlay, OH 45840 Phone: 419-422-6717 | |
Dr. Alan T. Tong, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1641 North Lake Ct, Findlay, OH 45840 Phone: 419-425-1510 Fax: 419-425-1736 | |
Dr. Marilyn Joy Kindig Stahl, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 301 W Wallace St, Findlay, OH 45840 Phone: 419-424-0180 | |
Dr. Emil Christian Ziegler, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 532 Yorkshire Dr, Findlay, OH 45840 Phone: 419-423-8822 |